Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 75, Issue 2, 2010, Pages 128-136

  Paillard Giteau, A ^a   Tran, V T ^a   Thomas, O ^a   Garric, X ^b   Coudane, J ^b   Marchal, S ^c   Chourpa, I ^d   Benoit J P ^a   Montero Menei, C N ^a   Venier Julienne, M C ^a  

^a UNIVERSITÉ D'ANGERS   (France)

^b UNIVERSITÉ DE MONTPELLIER   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE TOURS   (France)

Author keywords

Lysozyme; Microspheres; Poloxamer; Poly(lactic co glycolic acid) (PLGA); Protein; Sustained release

Indexed keywords

BOVINE SERUM ALBUMIN; LYSOZYME; MICROSPHERE; POLOXAMER; POLYGLACTIN;

ADSORPTION KINETICS; ARTICLE; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); EMULSION; ENZYME RELEASE; HYDROPHILICITY; IN VITRO STUDY; MICROENCAPSULATION; MOLECULAR STABILITY; POLYMERIZATION; PROTEIN INTERACTION; SURFACE PROPERTY;

ADSORPTION; ANIMALS; CATTLE; CHEMICAL PRECIPITATION; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; EMULSIONS; EXCIPIENTS; LACTIC ACID; MICROSPHERES; MURAMIDASE; POLOXAMER; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; POLYMERS; SERUM ALBUMIN, BOVINE; TIME FACTORS;

EID: 77952959253     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.03.005     Document Type: Article

References (59)

1. Schwendeman S.P., Cardamone M., Klibanov A., Langer R., Brandon M.R. Stability of proteins and their delivery from biodegradable polymer microspheres. Microparticulate Systems for the Delivery of Proteins and Vaccines 1996, 1-49. New York, Marcel Dekker. S. Cohen, H. Bernstein (Eds.).
2. Wang W. Protein aggregation and its inhibition in biopharmaceutics. Int. J. Pharm. 2005, 289(1-2):1-30.
3. van de Weert M., Hennink W.E., Jiskoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm. Res. 2000, 17(10):1159-1167.
4. Bilati U., Allemann E., Doelker E. Strategic approaches for overcoming peptide and protein instability within biodegradable nano and microparticles. Eur. J. Pharm. Biopharm. 2005, 59(3):375-388.
5. Tamber H., Johansen P., Merkle H.P., Gander B. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv. Drug. Del. Rev. 2005, 57(3 SPEC. ISS.):357-376.
6. Pean J.M., Venier-Julienne M.C., Boury F., Menei P., Denizot B., Benoit J.P. NGF release from poly(d,l-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability. J. Control Release 1998, 56(1-3):175-187.
7. Pean J.M., Boury F., Venier-Julienne M.C., Menei P., Proust J.E., Benoit J.P. Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?. Pharm. Res. 1999, 16(8):1294-1299.
8. Perez C., Castellanos I.J., Costantino H.R., Al-Azzam W., Griebenow K. Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers. J. Pharm. Pharmacol. 2002, 54(3):301-313.
9. Lee E.S., Kwon M.J., Lee H., Kim J.J. Stabilization of protein encapsulated in poly(lactide-co-glycolide) microspheres by novel viscous S/W/O/W method. Int. J. Pharm. 2007, 331(1):27-37.
10. Kim H.K., Chung H.J., Park T.G. Biodegradable polymeric microspheres with " open/closed" pores for sustained release of human growth hormone. J. Control Release 2006, 112(2):167-174.
11. Park J.H., Ye M., Yeo Y., Lee W.K., Paul C., Park K. Reservoir-type microcapsules prepared by the solvent exchange method: effect of formulation parameters on microencapsulation of lysozyme. Mol. Pharm. 2006, 3(2):135-143.
12. Crotts G., Park T.G. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. J. Microencapsul. 1998, 15(6):699-713.
13. Kim H.K., Park T.G. Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism. Biotechnol. Bioeng. 1999, 65(6):659-667.
14. Blanco D., Alonso M.J. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur. J. Pharm. Biopharm. 1998, 45(3):285-294.
15. Park T.G., Yong Lee H., Sung Nam Y. A new preparation method for protein loaded poly(d,l-lactic-co-glycolic acid) microspheres and protein release mechanism study. J. Control Release 1998, 55(2-3):181-191.
16. Rashkov I., Manolova N., Li S.M., Espartero J.L., Vert M. Synthesis, characterization, and hydrolytic degradation of PLA/PEO/PLA triblock copolymers with short poly(l-lactic acid) chains. Macromolecules 1996, 29(1):50-56.
17. Aubert-Pouessel A., Bibby D.C., Venier-Julienne M.C., Hindre F., Benoit J.P. A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres. Pharm. Res. 2002, 19(7):1046-1051.
18. Bezemer J.M., Radersma R., Grijpma D.W., Dijkstra P.J., van Blitterswijk C.A. Microspheres for protein delivery prepared from amphiphilic multiblock copolymers. 1. Influence of preparation techniques on particle characteristics and protein delivery. J. Control Release 2000, 67:233-248. FJ.
19. Mao Y., Thompson M.J., Wang Q., tsai E.W. Quantification of poloxamers in pharmaceutical formulation using size exclusion chromatography and colorimetric methods. J. Pharm. Biomed. Anal. 2004, 35(5):1127-1142.
20. Ghebeh H., Handa-Corrigan A., Butler M. Development of an assay for the measurement of the surfactant pluronic F-68 in mammalian cell culture medium. Anal. Biochem. 1998, 262(1):39-44.
21. Sturesson C., Carlfors J. Incorporation of protein in PLG-microspheres with retention of bioactivity. J. Control Release 2000, 67(2-3):171-178.
22. Jiang G., Qiu W., DeLuca P.P. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres. Pharm. Res. 2003, 20(3):452-459.
23. Giteau A., Venier-Julienne M.C., Aubert-Pouëssel A., Benoit J.P. How to achieve sustained and complete protein release from PLGA-based microparticles?. Int. J. Pharm. 2008, 350(1-2):14-26.
24. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int. J. Pharm. 1999, 185(2):129-188.
25. Tsai T. Adsorption of peptides to poly(d,l-lactide-co-glycolide): 2. Effect of solution properties on the adsorption. Int. J. Pharm. 1996, 127:43-52.
26. Sanchez A., Villamayor B., Guo Y., McIver J., Alonso M.J. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres. Int. J. Pharm. 1999, 185(2):255-266.
27. Johansen P., Men Y., Audran R., Corradin G., Merkle H.P., Gander B. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives. Pharm. Res. 1998, 15(7):1103-1110.
28. Jiang W., Schwendeman S.P. Stabilization of a model formalinized protein antigen encapsulated in poly(lactide-co-glycolide)-based microspheres. J. Pharm. Sci. 2001, 90(10):1558-1569.
29. Morlock M., Koll H., Winter G., Kissel T. Microencapsulation of rh-erythropoietin, using biodegradable poly(d,l-lactide-co-glycolide): protein stability and the effects of stabilizing excipients. Eur. J. Pharm. Biopharm. 1997, 43:29-36.
30. Morita T., Horikiri Y., Suzuki T., Yoshino H. Applicability of various amphiphilic polymers to the modification of protein release kinetics from biodegradable reservoir-type microspheres. Eur. J. Pharm. Biopharm. 2001, 51(1):45-53.
31. King T.W., Patrick C.W. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(d,l-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique. J. Biomed. Mater. Res. 2000, 51(3):383-390.
32. Malzert-Fréon A., Abillon O., Proust J.E., Gref R., Benoit J.P., Boury F. Interactions between hen egg-white lysozyme, PEG2000, and PLA50 at the air-water interface. Colloids Surfaces B: Biointerfaces 2005, 42(2):97-106.
33. Zhu G., Mallery S.R., Schwendeman S.P. Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide). Nat. Biotechnol. 2000, 18(1):52-57.
34. Cleek T.K.C., Eskin R.L., Mikos S.G. Microparticles of poly(d,l-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug delivery. J. Control Release 1997, 48:259-268. AG.
35. Lavelle E.C., Yeh M.K., Coombes A.G., Davis S.S. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Vaccine 1999, 17(6):512-529.
36. Yeh M.K. The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. J. Microencapsul. 2000, 17(6):743-756.
37. Carrasquillo K.G., Stanley A.M., Aponte-Carro J.C., De Jesus P., Costantino H.R., Bosques C.J., Griebenow K. Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. J. Control Release 2001, 76(3):199-208.
38. Giteau A., Venier-Julienne M.-C., Marchal S., Courthaudon J.-L., Sergent M., Montero-Menei C., Verdier J.-M., Benoit J.-P. Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres. Eur. J. Pharm. Biopharm. 2008, 70(1):127-136.
39. Ding A.G., Schwendeman S.P. Acidic microclimate pH distribution in PLGA microspheres monitored by confocal laser scanning microscopy. Pharm. Res. 2008, 25(9):2041-2052.
40. Park T.G., Lee H.Y., Nam Y.S. A new preparation method for protein loaded poly(d,l-lactic-co-glycolic acid) microspheres and protein release mechanism study. J. Control Release 1998, 55(2-3):181-191.
41. Jiang G., Woo B.H., Kang F., Singh J., DeLuca P.P. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(d,l-lactide-co-glycolide) microspheres. J. Control Release 2002, 79(1-3):137-145.
42. Diwan M., Park T.G. Pegylation enhances protein stability during encapsulation in PLGA microspheres. J. Control Release 2001, 73(2-3):233-244.
43. Sah H. Stabilization of proteins against methylene chloride/water interface-induced denaturation and aggregation. J. Control Release 1999, 58(2):143-151.
44. Blanco D., Alonso M.J. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur. J. Pharm. Biopharm. 1998, 45(3):285-294.
45. Tan J.S., Butterfield D.E., Voycheck C.L., Caldwell K.D., Li J.T. Surface modification of nanoparticles by PEO/PPO block copolymers to minimize interactions with blood components and prolong blood circulation in rats. Biomaterials 1993, 14(11):823-833.
46. Goppert T.M., Muller R.H. Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). Eur. J. Pharm. Biopharm. 2005, 60(3):361-372.
47. Duncan M., Joanne M., Warchol M. Influence of surfactants upon protein/peptide adsorption to glass and propylene. Int. J. Pharm. 1995, 120:179-188.
48. Amiji M., Park K. Prevention of protein adsorption and platelet adhesion on surfaces by PEO/PPO/PEO triblock copolymers. Biomaterials 1992, 13(10):682-692.
49. Sanchez A., Tobio M., Gonzalez L., Fabra A., Alonso M.J. Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha. Eur. J. Pharm. Sci. 2003, 18(3-4):221-229.
50. Lee R.C., Despa F., Guo L., Betala P., Kuo A., Thiyagarajan P. Surfactant copolymers prevent aggregation of heat denatured lysozyme. Ann. Biomed. Eng. 2006, 34(7):1190-1200.
51. Kiss E., Dravetzky K., Hill K., Kutnyanszky E., Varga A. Protein interaction with a pluronic-modified poly(lactic acid) Langmuir monolayer. J. Colloid Interface Sci. 2008, 325:337-345.
52. Alexandridis P., Holzwarth J., Hatton T. Micellization of poly(ethylene oxide)-poly(propylene oxide) triblock copolymers in aqueous solutions: thermodynamics of copolymer association. Macromolecules 1994, 27:2414-2425.
53. Wu Y.L. Effect of salt on the phase behaviour of F68 triblock PEO/PPO/PEO. J. Phys.: Condens. Matter 2006, 18:4461-4470.
54. Li Y.X., Kissel T. Synthesis and properties of biodegradable ABA triblock copolymers consisting of poly(l-lactic acid) or poly(l-lactic-co-glycolic acid) A-blocks attached to central poly(oxyethylene) B-blocks. J. Control Release 1993, 27(3):247-257.
55. Kissel T., Li Y., Unger F. ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins. Adv. Drug Del. Rev. 2002, 54(1):99-134.
56. Mader K., Bittner B., Li Y., Wohlauf W., Kissel T. Monitoring microviscosity and microacidity of the albumin microenvironment inside degrading microparticles from poly(lactide-co-glycolide) (PLG) or ABA-triblock polymers containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethyleneoxide) B blocks. Pharm. Res. 1998, V15(5):787-793.
57. Bittner B., Witt C., Mader K., Kissel T. Degradation and protein release properties of microspheres prepared from biodegradable poly(lactide-co-glycolide) and ABA tribock copolymers: influence of buffer media on polymer erosion and bovine serum albumin release. J. Control Release 1999, 60:297-309.
58. Kissel T., Li Y.X., Volland C., Gorich S., Koneberg R. Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene oxide) B blocks. J. Control Release 1996, 39(2-3):315-326.
59. Morlock M., Kissel T., Li Y.X., Koll H., Winter G. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. J. Control Release 1998, 56(1-3):105-115.